Argyle Capital Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$592K Buy
7,621
+34
+0.4% +$2.81K 0.37% 84
2026
Q2
$643K Hold
7,587
– – 0.4% 76
2026
Q1
$635K Hold
7,587
– – 0.46% 72
2025
Q4
$509K Hold
7,587
– – 0.37% 84
2025
Q3
$513K Hold
7,587
– – 0.37% 78
2025
Q2
$565K Hold
7,587
– – 0.47% 63
2025
Q1
$477K Hold
7,587
– – 0.41% 69
2024
Q4
$432K Buy
+7,587
New +$449K 0.37% 80

Other funds holding CTVA

Argyle Capital Partners's CTVA Position: Q3 2026 in Review

Argyle Capital Partners increased its Corteva (CTVA) stake by 0.45% in Q3 2026, buying an estimated $2.81K and bringing the position to 7,621 shares worth $592K. The position accounts for 0.37% of the portfolio, ranked #84.

Argyle Capital Partners first reported a position in CTVA in Q4 2024 and has held it in 8 quarters since. The position peaked at $643K in Q2 2026. 477 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Argyle Capital Partners held 7,621 shares of Corteva worth $592K as of Q3 2026.
  • Argyle Capital Partners bought 34 Corteva shares in Q3 2026, an estimated $2.81K.
  • Corteva made up 0.37% of Argyle Capital Partners's portfolio in Q3 2026, its #84 holding.
  • Argyle Capital Partners first reported a position in Corteva in Q4 2024 and has held it in 8 quarters since.
  • Argyle Capital Partners's Corteva position peaked at $643K in Q2 2026.
  • 477 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Argyle Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.